13 September 2024
Cancers | Feature Papers from the First Half of 2024 in the Section “Infectious Agents and Cancer”

You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the first half of 2024 in the Section “Infectious Agents and Cancer”, which are listed below:
1. “Precision Medicine for Nasopharyngeal Cancer—A Review of Current Prognostic Strategies”
by Luvita Suryani, Hazel P. Y. Lee, Wei Keat Teo, Zhi Kang Chin, Kwok Seng Loh and Joshua K. Tay
Cancers 2024, 16(5), 918; https://doi.org/10.3390/cancers16050918
Available online: https://www.mdpi.com/2072-6694/16/5/918
2. “Cultivable Microbiome Approach Applied to Cervical Cancer Exploration”
by Irma Berenice Mulato-Briones, Ismael Olan Rodriguez-Ildefonso, Julián Antonio Jiménez-Tenorio, Patricia Isidra Cauich-Sánchez, María del Socorro Méndez-Tovar, Gerardo Aparicio-Ozores, María Yicel Bautista-Hernández, Juan Francisco González-Parra, Jesús Cruz-Hernández, Ricardo López-Romero et al.
Cancers 2024, 16(2), 314; https://doi.org/10.3390/cancers16020314
Available online: https://www.mdpi.com/2072-6694/16/2/314
3. “COVID-19 Outcomes in Patients with Hematologic Malignancies in the Era of COVID-19 Vaccination and the Omicron Variant”
by Joaquín Martínez-López, Javier de la Cruz, Rodrigo Gil-Manso, José María Aspa-Cilleruelo, Víctor Jiménez Yuste, Cristian Escolano Escobar, Javier López-Jiménez, Cristina Jacome Yerovi, José-Ángel Hernández-Rivas, Rafael Duarte et al.
Cancers 2024, 16(2), 379; https://doi.org/10.3390/cancers16020379
Available online: https://www.mdpi.com/2072-6694/16/2/379
4. “Cancer and HIV: The Molecular Mechanisms of the Deadly Duo”
by Aadilah Omar,Natasia Marques and Nicole Crawford
Cancers 2024, 16(3), 546; https://doi.org/10.3390/cancers16030546
Available online: https://www.mdpi.com/2072-6694/16/3/546
5. “Epigenetic Mechanisms in Latent Epstein-Barr Virus Infection and Associated Cancers”
by Atharva S. Torne and Erle S. Robertson
Cancers 2024, 16(5), 991; https://doi.org/10.3390/cancers16050991
Available online: https://www.mdpi.com/2072-6694/16/5/991
6. “Hepatitis-C-Related Hepatocellular Carcinoma, Still a Relevant Etiology beyond a Hepatitis C Infection Cure”
by Elena Vargas-Accarino, Mónica Higuera, María Buti and Beatriz Mínguez
Cancers 2024, 16(8), 1521; https://doi.org/10.3390/cancers16081521
Available online: https://www.mdpi.com/2072-6694/16/8/1521
You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.
Cancers Editorial Office